AVISE® MTX Test from Exagen Supports Horizon Therapeutics plc Clinical Trial to Evaluate Pegloticase with Methotrexate to Enhance Response Rates for People Living with Uncontrolled Gout
24 oct. 2019 08h20 HE
|
Exagen, Inc.
SAN DIEGO, Oct. 24, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), is pleased to announce clinical study support for Horizon Therapeutics plc (Nasdaq: HZNP) to measure methotrexate...
Exagen to Be Honored with National Research Innovation Award by Lupus Foundation of America
21 oct. 2019 08h15 HE
|
Exagen, Inc.
SAN DIEGO, Oct. 21, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune...
Exagen Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
23 sept. 2019 13h36 HE
|
Exagen Inc.
SAN DIEGO, Calif., Sept. 23, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic...
Exagen Inc. Announces Pricing of Initial Public Offering
18 sept. 2019 19h14 HE
|
Exagen Inc.
San Diego, CA, Sept. 18, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic...
Exagen and the University of Washington Collaborate on Lupus and Rheumatoid Arthritis Research
19 août 2019 08h57 HE
|
Exagen Inc.
San Diego, CA and Albuquerque, NM, Aug. 19, 2019 (GLOBE NEWSWIRE) -- Exagen Inc., an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic...
New Biomarker Available to Offer Insight into Thrombosis for Lupus Sufferers
24 avr. 2019 09h55 HE
|
Exagen Diagnostics, Inc.
San Diego, CA and Albuquerque, NM, April 24, 2019 (GLOBE NEWSWIRE) -- Exagen Inc., a leader in helping rheumatologist and their patients in the diagnosis, prognosis, and management of chronic...
Exagen Inc. to Present at the Cowen and Company 39th Annual Health Care Conference 2019
11 févr. 2019 09h58 HE
|
Exagen Diagnostics, Inc.
Albuquerque, NM and San Diego, CA, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Exagen, a leader in autoimmune life sciences, today announced that it will present at the Cowen and Company 39th Annual Health...
Exagen Diagnostics to Present at The Piper Jaffray 30th Annual Heathcare Conference
13 nov. 2018 09h30 HE
|
Exagen Diagnostics, Inc.
ALBUQUERQUE, NM and SAN DIEGO, CA, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Exagen Diagnostics, a leader in autoimmune life sciences, today announced that it will present at the Piper Jaffray 30th Annual...
Exagen Diagnostics to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum
30 oct. 2018 10h30 HE
|
Exagen Diagnostics, Inc.
Albuquerque, NM and San Diego, CA, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Exagen Diagnostics, a leader in autoimmune life sciences, today announced that President and Chief Executive Officer, Ron Rocca,...
Exagen Announces Launch of Novel Biomarker PC4d Associated with Thrombosis in Lupus
12 oct. 2018 10h01 HE
|
Exagen Diagnostics, Inc.
ALBUQUERQUE, NM and SAN DIEGO, CA, Oct. 12, 2018 (GLOBE NEWSWIRE) -- Exagen Diagnostics, a leader in autoimmune life sciences, announced today that it will be updating the popular AVISE® SLE Monitor...